Search Results - "DETJEN, K."

Refine Results
  1. 1

    Interferon-γ Release Assays Improve the Diagnosis of Tuberculosis and Nontuberculous Mycobacterial Disease in Children in a Country with a Low Incidence of Tuberculosis by Detjen, A. K., Keil, T., Roll, S., Hauer, B., Mauch, H., Wahn, U., Magdorf, K.

    Published in Clinical infectious diseases (01-08-2007)
    “…Background. Diagnosis of childhood tuberculosis (TB) is challenging. The widely used tuberculin skin test (TST) may produce -positive results because of…”
    Get full text
    Journal Article
  2. 2

    Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children: a systematic review and meta-analysis by Detjen, Anne K, Dr, DiNardo, Andrew R, MD, Leyden, Jacinta, Steingart, Karen R, MD, Menzies, Dick, MD, Schiller, Ian, MSc, Dendukuri, Nandini, PhD, Mandalakas, Anna M, MD

    Published in The lancet respiratory medicine (01-06-2015)
    “…Summary Background Microbiological confirmation of childhood tuberculosis is rare because of the difficulty of collection of specimens, low sensitivity of…”
    Get full text
    Journal Article
  3. 3

    Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting by Chegou, Novel N, Detjen, Anne K, Thiart, Lani, Walters, Elisabetta, Mandalakas, Anna M, Hesseling, Anneke C, Walzl, Gerhard

    Published in PloS one (15-05-2013)
    “…The diagnosis of childhood tuberculosis (TB) disease remains a challenge especially in young and HIV-infected children. Recent studies have identified…”
    Get full text
    Journal Article
  4. 4

    Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis [Review article] by MANDALAKAS, A. M, DETJEN, A. K, HESSELING, A. C, BENEDETTI, A, MENZIES, D

    “…BACKGROUND: Children infected with Mycobacterium tuberculosis have significant risk of developing tuberculosis (TB) and can therefore benefit from preventive…”
    Get full text
    Journal Article
  5. 5

    Importance of tuberculosis control to address child survival by Graham, Stephen M, Prof, Sismanidis, Charalambos, PhD, Menzies, Heather J, MD, Marais, Ben J, PhD, Detjen, Anne K, MD, Black, Robert E, Prof

    Published in The Lancet (British edition) (03-05-2014)
    “…In the past decade, national tuberculosis programmes in high-burden settings have given increased attention to the challenges of childhood tuberculosis. 2 In…”
    Get full text
    Journal Article
  6. 6

    Interferon γ inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis by Detjen, K M, Farwig, K, Welzel, M, Wiedenmann, B, Rosewicz, S

    Published in Gut (01-08-2001)
    “…BACKGROUND AND AIMS The poor prognosis of pancreatic cancer is partly due to resistance to a broad spectrum of apoptotic stimuli. To identify intact…”
    Get full text
    Journal Article
  7. 7

    Provision of Decentralized TB Care Services: A Detect-Treat-Prevent Strategy for Children and Adolescents Affected by TB by Zawedde-Muyanja, Stella, Reuter, Anja, Tovar, Marco A, Hussain, Hamidah, Loando Mboyo, Aime, Detjen, Anne K, Yuen, Courtney M

    Published in Pathogens (Basel) (01-12-2021)
    “…In this review, we discuss considerations and successful models for providing decentralized diagnosis, treatment, and prevention services for children and…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Short-Term Reproducibility of a Commercial Interferon Gamma Release Assay by Detjen, A K, Loebenberg, L, Grewal, H M S, Stanley, K, Gutschmidt, A, Kruger, C, Du Plessis, N, Kidd, M, Beyers, N, Walzl, G, Hesseling, A C

    Published in Clinical and Vaccine Immunology (01-08-2009)
    “…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  10. 10

    The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model by Scholz, A, Wagner, K, Welzel, M, Remlinger, F, Wiedenmann, B, Siemeister, G, Rosewicz, S, Detjen, K M

    Published in Gut (01-02-2009)
    “…Current systemic therapies for neuroendocrine tumours (NETs) do not provide sufficient control of tumour growth. However, efficient evaluation of novel drugs…”
    Get more information
    Journal Article
  11. 11

    Molecular and pharmacodynamic characteristics of the novel multi-target tumor growth inhibitor ZK 304709 by Siemeister, G., Luecking, U., Wagner, C., Detjen, K., Mc Coy, C., Bosslet, Klaus

    Published in Biomedicine & pharmacotherapy (01-07-2006)
    “…Loss of cell cycle control and tumor-induced neovascularization are major drivers of human tumor growth. The multi-target tumor growth inhibitor ZK 304709 is a…”
    Get full text
    Journal Article Conference Proceeding
  12. 12

    The proline TP53 variant stimulates likely lymphangiogenesis in an orthotopic mouse model of pancreatic cancer by Otto, N, Schulz, P, Scholz, A, Hauff, P, Schlegelberger, B, Detjen, K M, Wiedenmann, B

    Published in British journal of cancer (17-01-2012)
    “…Background: Pancreatic cancer is a deadly disease characterised by high incidence of TP53 mutations. Restoration of TP53 function is perceived as a highly…”
    Get full text
    Journal Article
  13. 13

    Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children by Kay, Alexander W, González Fernández, Lucia, Takwoingi, Yemisi, Eisenhut, Michael, Detjen, Anne K, Steingart, Karen R, Mandalakas, Anna M

    Published in Cochrane database of systematic reviews (27-08-2020)
    “…Every year, at least one million children become ill with tuberculosis and around 200,000 children die. Xpert MTB/RIF and Xpert Ultra are World Health…”
    Get more information
    Journal Article
  14. 14

    Inducible re-expression of p16 in an orthotopic mouse model of pancreatic cancer inhibits lymphangiogenesis and lymphatic metastasis by Schulz, P, Scholz, A, Rexin, A, Hauff, P, Schirner, M, Wiedenmann, B, Detjen, K

    Published in British journal of cancer (08-07-2008)
    “…Functional inactivation of the tumour suppressor protein p16 INK4a constitutes a key event in the multistep process of pancreatic ductal cell transformation…”
    Get full text
    Journal Article
  15. 15

    Interferon-gamma release assays for the detection of Mycobacterium tuberculosis infection in children with cancer by STEFAN, D. C, DIPPENAAR, A, DETJEN, A. K, SCHAAF, H. S, MARAIS, B. J, KRIEL, B, LOEBENBERG, L, WALZL, G, HESSELING, A. C

    “…SETTING: The paediatric oncology unit at Tygerberg Children's Hospital, South Africa.OBJECTIVES: To assess the use of the tuberculin skin test (TST) and two…”
    Get full text
    Journal Article
  16. 16

    The Union and Médecins Sans Frontières approach to operational research [State of the art series. Operational research. Number 2 in the series] by HARRIES, A. D, RUSEN, I. D, ZACHARIAH, R, REID, T, DETJEN, A. K, BERGER, S. D, BISSELL, K, HINDERAKER, S. G, EDGINTON, M, FUSSELL, M, FUJIWARA, P. I

    “…Operational research (OR) has become a hot topic at national meetings, international conferences and donor fora. The International Union Against Tuberculosis…”
    Get full text
    Journal Article
  17. 17
  18. 18

    PO-329 Genomic aberration in pancreatic neuroendocrine tumours (PNET) by Simon, T, Mamlouk, S, Khouja, S, Andrea, M, Dido, L, Detjen, K, Pavel, M, Rossner, F, Haybäck, J, Sers, C

    Published in ESMO open (01-07-2018)
    “…IntroductionRare tumours are poorly investigated and therefore heavily limited in possible therapeutic approaches, and subsequently therapeutic success. One…”
    Get full text
    Journal Article
  19. 19

    Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children by Kay, Alexander W, Ness, Tara, Verkuijl, Sabine E, Viney, Kerri, Brands, Annemieke, Masini, Tiziana, González Fernández, Lucia, Eisenhut, Michael, Detjen, Anne K, Mandalakas, Anna M, Steingart, Karen R, Takwoingi, Yemisi

    Published in Cochrane database of systematic reviews (06-09-2022)
    “…Every year, an estimated one million children and young adolescents become ill with tuberculosis, and around 226,000 of those children die. Xpert MTB/RIF Ultra…”
    Get more information
    Journal Article
  20. 20